Search results
Results from the WOW.Com Content Network
Ovarian hyperstimulation syndrome (OHSS) is a medical condition that can occur in some women who take fertility medication to stimulate egg growth, and in other women in sporadic cases. Most cases are mild, but rarely the condition is severe and can lead to serious illness or even death.
In ovarian hyperstimulation combined with IUI, women aged 38–39 years appear to have reasonable success during the first two cycles, with an overall live birth rate of 6.1% per cycle. [12] However, for women aged ≥40 years, the overall live birth rate is 2.0% per cycle, and there appears to be no benefit after a single cycle of COH/IUI. [ 12 ]
In rare cases, OHSS can kidney failure as well as blood clots; in very rare cases, OHSS can be life-threatening: In 2022, a 23-year-old woman from India died during an IVF procedure as OHSS caused ...
Controlled ovarian hyperstimulation is generally part of in vitro fertilization, and the aim is generally to develop multiple follicles (optimally between 11 and 14 antral follicles measuring 2–8 mm in diameter), [5] followed by transvaginal oocyte retrieval, co-incubation, followed by embryo transfer of a maximum of two embryos at a time. [6]
Radiation therapy can have a significant impact on female fertility. The damage induced varies greatly and is determined by factors such as the age of the patient along with the dose and duration of treatment given. [1] Estimates suggest that less than 2Gy of radiation could destroy half of a female’s immature oocytes.
A cyst may develop in either of the ovaries that are responsible for producing hormones and carrying eggs. Ovarian cysts can be of various types, such as dermoid cysts, endometrioma cysts, and the functional cyst. [medical citation needed] Symptoms: Abdominal bloating or swelling. Painful bowel movement. Pelvic pain before or after the ...
Theca lutein cyst is a type of bilateral functional ovarian cyst filled with clear, straw-colored fluid. These cysts result from exaggerated physiological stimulation (hyperreactio luteinalis) due to elevated levels of beta-human chorionic gonadotropin (beta-hCG) or hypersensitivity to beta-hCG.
Final maturation induction using a GnRH agonist is recommended in women with cancer undergoing fertility preservation, because ovarian hyperstimulation syndrome is associated with an increased risk of arterial thrombotic events such as stroke, myocardial infarction and peripheral arterial embolism, and this risk can add to an already increased ...